✦ LIBER ✦

Clevudine myopathy in patients with chronic hepatitis B

✍ Scribed by Byung Kook Kim; Jeeyoung Oh; So Young Kwon; Won Hyeok Choe; Soon Young Ko; Kyoung Hoon Rhee; Tae Ho Seo; So Dug Lim; Chang Hong Lee

Book ID: 116651923
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 398 KB
Volume: 51
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2009.04.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

18F-FDG PET/CT of drug-induced myopathy

18F-FDG PET/CT of drug-induced myopathy in a patient with chronic hepatitis B on long-term clevudine therapy

✍ Jeong Ah Lee; Hwan Sik Hwang; Dae-Hyun Yoo; Seung Sam Paik; Sung-June Jang; Youn 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 106 KB

926 NUCLEOSIDE ANALOGUE INDUCED MITOCHON

926 NUCLEOSIDE ANALOGUE INDUCED MITOCHONDRIAL TOXICITY WITH MYOPATHY IN CHRONIC HEPATITIS B PATIENTS WITH LONG-TERM CLEVUDINE [1-(2-DEOXY- 2-FLUORO-β-L-ARABINOFURANOSYL) THYMININE, L-FMAU] THERAPY

✍ S.Y. Park; M.K. Jung; S.W. Jeon; C.M. Cho; W.Y. Tak; Y.O. Kweon; S.K. Kim; Y.H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Mitochondrial myopathy caused by clevudi

Mitochondrial myopathy caused by clevudine therapy in chronic hepatitis B patients

✍ Won Young Tak; Soo Young Park; Min Kyu Jung; Seong Woo Jeon; Chang Min Cho; Youn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Telbivudine myopathy in a patient with c

Telbivudine myopathy in a patient with chronic hepatitis B

✍ Min Wang, Yuwei Da, Haodong Cai, Yan Lu, Liyong Wu, Jianping Jia 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 266 KB

Clevudine for chronic hepatitis B: antiv

Clevudine for chronic hepatitis B: antiviral response, predictors of response, and development of myopathy

✍ J.-H. Jang; J.-W. Kim; S.-H. Jeong; H.-J. Myung; H. S. Kim; Y. S. Park; S. H. Le 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

A phase II dose-escalating trial of clev

A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B

✍ Patrick Marcellin; Herve Mommeja-Marin; Stephen L. Sacks; George K. K. Lau; Dani 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

Current therapies available for the treatment of chronic hepatitis B are limited in their ability to result in a cure. Clevudine is a new pyrimidine analog with potent anti-hepatitis B virus (HBV) activity in vitro. A multicenter dose-escalation study evaluated clevudine at 10, 50, 100, and 200 mg o